Leaders in Cardiovascular Medicine
From blood to beating cells, visit med.stanford.edu/scvibiobank.html
Upcoming Events & Seminars
Frontiers in Cardiovascular Science
Global leaders in Medicine and Research
October 25, 2016
12:30 - 1:25pm @ LKSC LK130
Sushma Reddy, MD
Assistant Professor of Pediatrics (Cardiology) at the Lucile Salter Packard Children's Hospital, and
Francois Haddad, MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine, Stanford School of Medicine
Shutting off a gene implicated in insulin resistance leads to damaged mitochondria and decreased exercise capacity in mice.
Dr. Kazuki Kodo, former postdoc at CVI and now Asst Prof at Keio University, uses iPSCs to unravel mechanism of a common congenital heart disease
Congratulations to the 2016 Seed Grants Recipients
9/19/2016 - Our goal is to ignite and support new ideas that will improve how we diagnosis and treat cardiovascular diseases.
Congratulations to the Dorothy Dee & Marjorie Helene Boring Trust Award winners
Recipients are MD or PhD students within the Stanford School of Medicine who have demonstrated excellence and creativity in cardiovascular research
November 21, 2016 | 12 - 5 pm
Li Ka Shing Center
Lunch, science, wine & cheese
Heart muscle made from stem cells aid precision cardiovascular medicine
8/18/2016 - Heart muscle cells made from induced pluripotent stem cells share gene expression patterns with native donor tissue, researchers discovered.
Stanford Medicine Partners with AstraZeneca
7/22/2016 - This collaboration will focus on cardio-metabolic and respiratory diseases, oncology, mobile health, clinical trial management services, and education and training.
Ioannis Karakikes, PhD, Appointed Assistant Professor of Cardiothoracic Surgery
5/1/2016 - His research focuses on delineating the molecular mechanisms underling the pathogenesis of cardiomyopathies using patient-specific cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs), and also the development of biological therapies for heart failure.
Anti-tumor antibodies could counter atherosclerosis
7/20/2016 - A biological drug could be used to combat cardiovascular disease by targeting not mere risk factors such as high cholesterol or high blood pressure, but the actual lesions bearing direct responsibility: atherosclerotic plaques.
Frontiers in Cardiovascular Medicine 2016: Stanford-Gachon 3rd Annual Session
7/15/2016 - Congratulations to Andrew Goldstone for winning the Young Investigator Award!
Stanford-Karolinska Cardiovascular Research & Medicine Symposium
October 20, 2016
8:30 am – 5:30 pm
Li Ka Shing Center
Paul Berg Hall
Postdoc Imaging Fellowship Available
Funding Opportunities: Students and Fellows
Cardiovascular Links @ Stanford
- Dept of Cardiothoracic Surgery
- Div of Cardiovascular Medicine
- Div of Vascular Surgery
- Div of Interventional Radiology
- LPCH Pediatric Cardiology
- Stanford Cardiovascular Health
- CV-related Clinical Trials
- CV-related Training Programs & Fellowships
- Cardiovascular Pharmacology (Div of CVI)
- Medical School Events
- Stanford Cardiovascular Institute Biobank
- SIMR Program